China Approves the First Brain Chips for Sale—and Has a Plan to Dominate the Industry

China's swift approval of brain chips indicates a strategic push to dominate a field that could revolutionize medical treatments and cognitive enhancement. This aggressive stance contrasts sharply with the more measured pace of Western nations, raising questions about ethical implications and regulatory frameworks. As China positions itself as a leader in neurotechnology, the global balance of innovation and ethical standards in this sensitive area may be at risk.